Consistent with this observation, 20 weeks of CANA treatment significantly reduced liver fibrosis in MC4R-KO mice (Fig. 2d and e), associated with the suppression of fibrogenic genes such as Col1a1, Acta2, Tgfb1, and Timp1 (Fig. 2f). The gene discussed is ACTA2; the disease is Hepatic fibrosis.